Recuento de casos en los EE. UU.
Al 28 de septiembre del 2016 (5 a.m., hora estándar del este)
- La enfermedad por el virus del Zika y la infección congénita por el virus del Zika son afecciones que deben notificarse en todo el país.
- Esta actualización de la División de Enfermedades Arbovirales de los CDC incluye datos provisionales informados a ArboNET para el período entre el 01 de enero del 2015 y el 28 de septiembre del 2016.
Estados de los EE. UU.
- Casos informados de transmisión local a través de mosquitos: 59
- Casos informados asociados con viajes: 3565
- Casos informados de contagio en laboratorio: 1
- Total: 3,625
- Por transmisión sexual: 30
- Síndrome de Guillain-Barré: 12
Territorios de EE. UU.
- Casos informados de contagio a nivel local: 21,988
- Casos informados asociados con viajes: 81
- Total: 22069*
- Síndrome de Guillain-Barré: 39
*No se informan los casos de transmisión por vía sexual en los territorios de los EE. UU., debido a que con la transmisión local del virus del Zika no es posible determinar si la infección se produjo debido a una infección a través de los mosquitos o por vía sexual.
Laboratory-confirmed Zika virus disease cases reported to ArboNET by state or territory — United States, 2015–2016 (as of September 28, 2016)§
§Only includes cases meeting the probable or confirmed CSTE case definition and does not include asymptomatic infections unless the case is a pregnant woman with a complication of pregnancy
*Viajeros que regresan de áreas afectadas, sus contactos sexuales o bebés infectados in utero
†Presunta transmisión local a través de mosquitos
††Otro caso de transmisión en laboratorio
**Incluye un caso en el que se desconoce la vía de contagio entre personas.
***El Departamento de Salud de Puerto Rico está realizando el informe de casos de manera retroactiva, lo que conlleva a que haya más casos que lo normal en las últimas semanas.
| Estados | Casos asociados a viajes* N.° (% de casos en los estados) (N=3,566) | Casos a nivel local† N.° (% de casos en los estados) (N=59) |
|---|---|---|
| Alabama | 27 (1) | 0 (0) |
| Arizona | 31 (1) | 0 (0) |
| Arkansas | 10 (<1) | 0 (0) |
| California | 267 (7) | 0 (0) |
| Colorado | 36 (1) | 0 (0) |
| Connecticut | 58 (2) | 0 (0) |
| Delaware | 13 (<1) | 0 (0) |
| Distrito de Columbia | 23 (1) | 0 (0) |
| Florida | 672 (19) | 59 (100) |
| Georgia | 81 (2) | 0 (0) |
| Hawái | 12 (<1) | 0 (0) |
| Idaho | 3 (<1) | 0 (0) |
| Illinois | 70 (2) | 0 (0) |
| Indiana | 34 (1) | 0 (0) |
| Iowa | 16 (<1) | 0 (0) |
| Kansas | 15 (<1) | 0 (0) |
| Kentucky | 24 (1) | 0 (0) |
| Luisiana | 31 (1) | 0 (0) |
| Maine | 11 (<1) | 0 (0) |
| Maryland | 101 (3) | 0 (0) |
| Massachussetts | 76 (2) | 0 (0) |
| Michigan | 57 (2) | 0 (0) |
| Minesota | 47 (1) | 0 (0) |
| Misisipi | 23 (1) | 0 (0) |
| Misuri | 27 (1) | 0 (0) |
| Montana | 7 (<1) | 0 (0) |
| Nebraska | 11 (<1) | 0 (0) |
| Nevada | 14 (<1) | 0 (0) |
| Nuevo Hampshire | 9 (<1) | 0 (0) |
| Nueva Jersey | 133 (4) | 0 (0) |
| Nuevo México | 6 (<1) | 0 (0) |
| Nueva York | 811 (23) | 0 (0) |
| Carolina del Norte | 66 (2) | 0 (0) |
| Dakota del Norte | 1 (<1) | 0 (0) |
| Ohio | 52 (1) | 0 (0) |
| Oklahoma | 26 (1) | 0 (0) |
| Oregón | 27 (1) | 0 (0) |
| Pensilvania†† | 129 (4) | 0 (0) |
| Rhode Island | 32 (1) | 0 (0) |
| Carolina del Sur | 31 (1) | 0 (0) |
| Dakota del Sur | 1 (<1) | 0 (0) |
| Tennessee | 51 (1) | 0 (0) |
| Texas | 204 (6) | 0 (0) |
| Utah | 13** (<1) | 0 (0) |
| Vermont | 7 (<1) | 0 (0) |
| Virginia | 85 (2) | 0 (0) |
| Washington | 34 (1) | 0 (0) |
| Virginia Occidental | 11 (<1) | 0 (0) |
| Wisconsin | 38 (1) | 0 (0) |
| Wyoming | 2 (<1) | 0 (0) |
| Territorios | Casos asociados a viajes* N.° (% de casos en los territorios) (N=81) | Casos a nivel local† N.° (% de casos en los territorios) (N=21,988) |
| Samoa Americana | 6 (7) | 47 (<1) |
| Puerto Rico | 74 (91) | 21,535*** (98) |
| Islas Vírgenes (EE.UU.) | 1 (1) | 406 (2) |
*Viajeros que regresan de áreas afectadas, sus contactos sexuales o bebés infectados in utero
†Presunta transmisión local a través de mosquitos
††Otro caso de transmisión en laboratorio
**Incluye un caso en el que se desconoce la vía de contagio entre personas.
***El Departamento de Salud de Puerto Rico está realizando el informe de casos de manera retroactiva, lo que conlleva a que haya más casos que lo normal en las últimas semanas.
Case Counts in the US | Zika virus | CDC
Case Counts in the US
- US States and DC: 3,625
- US Territories: 22,069
*Source: ArboNET as of September 28, 2016
As of September 28, 2016 (5 am EST)
- Zika virus disease and Zika virus congenital infection are nationally notifiable conditions.
- This update from the CDC Arboviral Disease Branch includes provisional data reported to ArboNET for January 01, 2015 – September 28, 2016.
US States
- Locally acquired mosquito-borne cases reported: 59
- Travel-associated cases reported: 3,565
- Laboratory acquired cases reported: 1
- Total: 3,625
- Sexually transmitted: 30
- Guillain-Barré syndrome: 12
US Territories
- Locally acquired cases reported: 21,988
- Travel-associated cases reported: 81
- Total: 22,069*
- Guillain-Barré syndrome: 39
*Sexually transmitted cases are not reported for US territories because with local transmission of Zika virus it is not possible to determine whether infection occurred due to mosquito-borne or sexual transmission.
Laboratory-confirmed Zika virus disease cases reported to ArboNET by state or territory — United States, 2015–2016 (as of September 28, 2016)§
§Only includes cases meeting the probable or confirmed CSTE case definition and does not include asymptomatic infections unless the case is a pregnant woman with a complication of pregnancy
*Travelers returning from affected areas, their sexual contacts, or infants infected in utero
†Presumed local mosquito-borne transmission
††One additional case acquired through laboratory transmission
**Includes one case with unknown route of person-to-person transmission.
***The Puerto Rico Department of Health is retroactively reporting cases, resulting in larger than normal increases in cases in recent weeks.
| States | Travel-associated cases* No. (% of cases in states) (N=3,566) | Locally acquired cases† No. (% of cases in states) (N=59) |
|---|---|---|
| Alabama | 27 (1) | 0 (0) |
| Arizona | 31 (1) | 0 (0) |
| Arkansas | 10 (<1) | 0 (0) |
| California | 267 (7) | 0 (0) |
| Colorado | 36 (1) | 0 (0) |
| Connecticut | 58 (2) | 0 (0) |
| Delaware | 13 (<1) | 0 (0) |
| District of Columbia | 23 (1) | 0 (0) |
| Florida | 672 (19) | 59 (100) |
| Georgia | 81 (2) | 0 (0) |
| Hawaii | 12 (<1) | 0 (0) |
| Idaho | 3 (<1) | 0 (0) |
| Illinois | 70 (2) | 0 (0) |
| Indiana | 34 (1) | 0 (0) |
| Iowa | 16 (<1) | 0 (0) |
| Kansas | 15 (<1) | 0 (0) |
| Kentucky | 24 (1) | 0 (0) |
| Louisiana | 31 (1) | 0 (0) |
| Maine | 11 (<1) | 0 (0) |
| Maryland | 101 (3) | 0 (0) |
| Massachusetts | 76 (2) | 0 (0) |
| Michigan | 57 (2) | 0 (0) |
| Minnesota | 47 (1) | 0 (0) |
| Mississippi | 23 (1) | 0 (0) |
| Missouri | 27 (1) | 0 (0) |
| Montana | 7 (<1) | 0 (0) |
| Nebraska | 11 (<1) | 0 (0) |
| Nevada | 14 (<1) | 0 (0) |
| New Hampshire | 9 (<1) | 0 (0) |
| New Jersey | 133 (4) | 0 (0) |
| New Mexico | 6 (<1) | 0 (0) |
| New York | 811 (23) | 0 (0) |
| North Carolina | 66 (2) | 0 (0) |
| North Dakota | 1 (<1) | 0 (0) |
| Ohio | 52 (1) | 0 (0) |
| Oklahoma | 26 (1) | 0 (0) |
| Oregon | 27 (1) | 0 (0) |
| Pennsylvania†† | 129 (4) | 0 (0) |
| Rhode Island | 32 (1) | 0 (0) |
| South Carolina | 31 (1) | 0 (0) |
| South Dakota | 1 (<1) | 0 (0) |
| Tennessee | 51 (1) | 0 (0) |
| Texas | 204 (6) | 0 (0) |
| Utah | 13** (<1) | 0 (0) |
| Vermont | 7 (<1) | 0 (0) |
| Virginia | 85 (2) | 0 (0) |
| Washington | 34 (1) | 0 (0) |
| West Virginia | 11 (<1) | 0 (0) |
| Wisconsin | 38 (1) | 0 (0) |
| Wyoming | 2 (<1) | 0 (0) |
| Territories | Travel-associated cases* No. (% of cases in territories) (N=81) | Locally acquired cases† No. (% of cases in territories) (N=21,988) |
| American Samoa | 6 (7) | 47 (<1) |
| Puerto Rico | 74 (91) | 21,535*** (98) |
| US Virgin Islands | 1 (1) | 406 (2) |
*Travelers returning from affected areas, their sexual contacts, or infants infected in utero
†Presumed local mosquito-borne transmission
††One additional case acquired through laboratory transmission
**Includes one case with unknown route of person-to-person transmission.
***The Puerto Rico Department of Health is retroactively reporting cases, resulting in larger than normal increases in cases in recent weeks.
No hay comentarios:
Publicar un comentario